BlackRock’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-844,078
Closed -$179M 3247
2014
Q4
$179M Sell
844,078
-623,130
-42% -$124M 0.26% 81
2014
Q3
$261M Buy
1,467,208
+676,607
+86% +$112M 0.38% 55
2014
Q2
$134M Sell
790,601
-53,980
-6% -$8.4M 0.2% 115
2014
Q1
$105M Sell
844,581
-39,935
-5% -$4.86M 0.17% 131
2013
Q4
$98.3M Sell
884,516
-411,267
-32% -$39.3M 0.16% 142
2013
Q3
$117M Sell
1,295,783
-213,532
-14% -$19.2M 0.22% 99
2013
Q2
$127M Buy
+1,509,315
New +$157M 0.25% 78

Other funds holding AGN

BlackRock's AGN Position: Q1 2015 in Review

BlackRock sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 844,078 shares — an estimated $179M sold.

BlackRock first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $261M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock sold 844,078 Allergan Inc shares in Q1 2015, an estimated $179M.
  • BlackRock first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock's Allergan Inc position peaked at $261M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock's 13F filing for Q1 2015, filed 13 May 2015.